<DOC>
	<DOCNO>NCT00329628</DOCNO>
	<brief_summary>The purpose study assess 10 mg BAY 59-7939 , take daily tablet , safe prevent blood clot may form total hip replacement operation .</brief_summary>
	<brief_title>Rivaroxaban ( 10mg ) Given Once Daily Patients Undergoing Total Hip Replacement Compared Enoxaparin</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male female patient age 18 year Patients schedule elective total hip replacement Planned , stag total bilateral hip replacement Active bleeding high risk bleed contraindicate treatment low molecular weight heparin Contraindication list label condition preclude patient treatment enoxaparin Conditions prohibit bilateral venography ( e.g . amputation one leg , allergy contrast medium )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Thromboembolism</keyword>
</DOC>